Security
FREHY · Fresh2 Group Ltd
FREHYNASDAQotherHistorical · closed Nov 20, 2025CIK 1786511Updated Sep 26, 2026
Name history
AnPac Bio-Medical Science Co., Ltd. · through May 2, 2023
FREHY price & chart
Historical security
This listing closed Nov 20, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,867,000Source | 10,592,000Source | 7,645,000Source | 7,611,000Source |
| Property, Plant and Equipment, NetUSD | 2,491,000Source | 3,180,000Source | 2,953,000Source | 2,710,000Source |
| GoodwillUSD | — | 2,002,000Source | 341,000Source | 319,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,439,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 271,000Source | 1,452,000Source | 462,000Source | 880,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 324,000Source | 872,000Source | 1,194,000Source | 186,000Source |
| Inventory, NetUSD | 30,000Source | 77,000Source | 48,000Source | 45,000Source |
| Assets, CurrentUSD | 1,986,000Source | 3,696,000Source | 3,262,000Source | 3,185,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,046,000Source | — | — | — |
| Other Assets, NoncurrentUSD | — | — | 71,000Source | 144,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,230,000Source | 10,385,000Source | 7,143,000Source | 9,898,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 797,000Source | — | — | — |
| Additional Paid in CapitalUSD | 81,898,000Source | — | — | — |
| Retained Earnings (Accumulated Deficit)USD | -83,735,000Source | -74,639,000Source | -54,705,000Source | -39,712,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 618,000Source | 711,000Source | 735,000Source | 303,000Source |
| Stockholders' Equity Attributable to ParentUSD | -1,982,000Source | -706,000Source | 452,000Source | -2,294,000Source |
| Additional Paid in Capital, Common StockUSD | — | 73,021,000Source | 54,298,000Source | 37,021,000Source |
| Liabilities and EquityUSD | 5,867,000Source | 10,592,000Source | 7,645,000Source | 7,611,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 6,128,000Source | 9,872,000Source | 6,670,000Source | 9,509,000Source |
| Operating Lease, Liability, CurrentUSD | 114,000Source | — | — | — |
| Accounts Payable, CurrentUSD | 303,000Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 945,000Source | — | — | — |
| Deferred Income Tax Liabilities, NetUSD | — | 339,000Source | 160,000Source | 163,000Source |
| Other Liabilities, NoncurrentUSD | 157,000Source | 174,000Source | 313,000Source | 226,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 619,000Source | 913,000Source | 50,000Source | 7,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 360,000Source | — | — | — |
| Short-term InvestmentsCNY | — | 265,826,000Source | — | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -15,019,000Source | -18,846,000Source | -12,347,000Source | -14,596,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 682,000Source | 614,000Source | 474,000Source | 383,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,164,000Source | 5,362,000Source | 2,722,000Source | 4,719,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -420,000Source | -242,000Source | 1,112,000Source | -185,000Source |
| Increase (Decrease) in InventoriesUSD | -41,000Source | 28,000Source | 7,000Source | 80,000Source |
| Increase (Decrease) in Accounts PayableUSD | -91,000Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | -313,000Source | -185,000Source | -13,000Source | 13,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -7,983,000Source | -11,252,000Source | -9,035,000Source | -6,980,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -231,000Source | -618,000Source | -380,000Source | -497,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 211,000Source | 612,000Source | 378,000Source | 401,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 7,173,000Source | 13,090,000Source | 9,339,000Source | 6,622,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -1,070,000Source | 979,000Source | -477,000Source | -971,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 271,000Source | 1,452,000Source | 462,000Source | 880,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 39,000Source | 343,000Source | 370,000Source | 148,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | 5,362,000Source | 2,722,000Source | 4,719,000Source |
| Amortization of Intangible AssetsUSD | 130,000Source | — | — | — |
| Deferred Other Tax Expense (Benefit)USD | 313,000Source | — | — | — |
| DepreciationUSD | 548,000Source | 428,000Source | 374,000Source | 296,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | 1,098,000Source | -761,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -114,000Source | -32,000Source | -102,000Source | -461,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -594,000Source |
| General and Administrative ExpenseUSD | 10,263,000Source | 12,660,000Source | 11,457,000Source | 10,167,000Source |
| GoodwillUSD | — | 2,002,000Source | 341,000Source | 319,000Source |
| Goodwill, Impairment LossCNY | 12,758,000Source | 2,223,000Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | 1,147,000Source | 601,000Source | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | 23,000Source | 21,000Source | -2,000Source | 27,000Source |
| Income Tax Expense (Benefit)USD | -309,000Source | -185,000Source | -13,000Source | -31,000Source |
| Inventory Write-downUSD | — | — | 6,000Source | 44,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,772,000Source | -18,628,000Source | -12,333,000Source | -14,515,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -247,000Source | -218,000Source | -14,000Source | -81,000Source |
| Other Nonoperating Income (Expense)USD | -9,000Source | 155,000Source | 1,394,000Source | -1,023,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 54,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 6,838,000Source |
| Proceeds from Noncontrolling InterestsUSD | 23,000Source | — | 57,000Source | 88,000Source |
| Proceeds from Stock Options ExercisedUSD | 6,000Source | 409,000Source | 1,000Source | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 1,428,000Source | 2,822,000Source | 3,143,000Source | 1,558,000Source |
| Cost of RevenueUSD | — | 899,000Source | 1,169,000Source | 869,000Source |
| Operating Income (Loss)USD | -15,195,000Source | -17,591,000Source | -14,491,000Source | -12,795,000Source |
| Other Nonoperating Income (Expense)USD | -9,000Source | 155,000Source | 1,394,000Source | -1,023,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -15,328,000Source | -19,031,000Source | -12,360,000Source | -14,627,000Source |
| Income Tax Expense (Benefit)USD | -309,000Source | -185,000Source | -13,000Source | -31,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -247,000Source | -218,000Source | -14,000Source | -81,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,772,000Source | -18,628,000Source | -12,333,000Source | -14,515,000Source |
| Earnings Per Share, BasicUSD per share | -0.39Source | -1.37Source | — | — |
| Earnings Per Share, DilutedUSD per share | -0.39Source | -1.37Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 38,242,073Source | 13,605,515Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 38,242,073Source | 13,605,515Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 130,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | 4,000Source | — | — | 18,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | 1,098,000Source | -761,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -114,000Source | -32,000Source | -102,000Source | -461,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | — | -594,000Source |
| General and Administrative ExpenseUSD | 10,263,000Source | 12,660,000Source | 11,457,000Source | 10,167,000Source |
| Goodwill, Impairment LossCNY | 12,758,000Source | 2,223,000Source | 0Source | 0Source |
| Gross ProfitUSD | 1,208,000Source | 1,923,000Source | 1,974,000Source | 689,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -15,328,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | -5,277,000Source | -4,494,000Source | -6,490,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 23,000Source | 21,000Source | -2,000Source | 27,000Source |
| Interest ExpenseUSD | 34,000Source | 668,000Source | 175,000Source | 375,000Source |
| Other Cost of Operating RevenueUSD | 1,746,000Source | — | — | — |
| Other ExpensesUSD | 565,000Source | — | — | — |
| Other General and Administrative ExpenseUSD | 1,052,000Source | — | — | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 54,000Source |
| Research and Development ExpenseUSD | 1,381,000Source | 2,543,000Source | 1,774,000Source | 1,413,000Source |
| Selling and Marketing ExpenseUSD | 1,762,000Source | 3,361,000Source | 3,015,000Source | 1,958,000Source |